GROWERS
Abba Medix Group Inc. carries on business through its wholly-owned subsidiary Abba Medix Corp. Abba Medix was established in August 2013 to capitalize on the dramatically changing rules governing medical marijuana production in Canada. Abba submitted its initial application under the MMPR licensing program in November of 2013. Abba’s 19,000 sq. ft. Pickering, Ontario growing facility is complete and ready for Health Canada inspection. It is currently awaiting approval from Health Canada to produce medical cannabis. CSE:ABA Last closing price .28
Liberty Leaf Holdings Ltd. is a new, Canadian-based, public company whose objective is to be at the forefront of the medicinal and recreational cannabis industry...accelerating revenue-generating businesses within this dynamic and fast-growing sector. Active projects North Road Ventures. North Road currently occupies a leased commercial space in Metro Vancouver. North Road has an application pending with Health Canada for a MMPR license for the distribution of up to 1,320 pounds of marihuana in its first year of operations.CSE:LIB – Last closing price .27
MATICA ENTERPRISES INC. is a diversified Canadian company with interests in mineral exploration and medical marijuana. Matica still holds a fifty percent interest in THC Dispensaries Canada Inc. a Nova Scotia Company with “Right to Build“ status awaiting it's MMPR License. Matica, through its wholly owned subsidiary Ravenline Exploration Ltd. has mineral interests in Nevada. Ravenline has been focusing on minerals used in the renewable energy sector, primarily lithium and graphite. CSE:MMJ – Last closing price .01 – currently halted.
MYM Nutraceuticals Inc. is a company thathas applied to become a Licensed Producer under Canada’s Marijuana for Medical Purposes Regulations.The company has an extensive list of industry assets that make it well prepared for commercial distribution of medical marijuana, including a growing facility property, exclusive access to patients and many years of industry expertise on the company’s board of directors and staff. CSE:MYM – Last closing price .05
Supreme Pharmaceuticals Inc is a publicly traded marijuana company based in Toronto, Canada. Supreme’s wholly owned subsidiary, 7ACRES/AMMcan, was issued a Canadian federal license to cultivate medical marijuana pursuant to the Marijuana for Medical Purposes Regulations on March 11, 2016 (now the ACMPR). Supreme is one of the newest marijuana Licensed Producers (LP) in Canada’s marijuana market, and is well positioned with its high capacity innovative hybrid greenhouse and B2B focused business model. CSE:SL- Last closing price $1.35
VODIS Innovative Pharmaceuticals Inc. is positioned to be among the first pharmaceutical corporations in Canada to produce and market medical marijuana under license from Health Canada in accordance with the existing Narcotic Control Regulations (“NCR”) and the new Marihuana for Medical Purposes Regulations (“MMPR”) that came into effect on April 1st, 2014. Vodis filed it’s MMPR in August of 2013 and in January of 2014 received a ‘ready to build’ letter from Health Canada. IT IS CURRENTLY AWAITING FINAL INSPECTION FROM HEALTH CANADA.The company has been operating under the MMAR regulations at its 12,000 square foot production facility, consisting of six rooms. This was recently upgraded to eight rooms, consisting of between 40 and 50 lights per room. The estimated production when fully operational under the MMPR license is between 150-200 pounds per month of award winning cannabis. CSE:VP – Last closing price .13
Wildflower is a cannabis company focused on developing and designing branded products in the marijuana sector. Wildflower works exclusively in Washington State where such activity is permitted and regulated by State law, through entities which hold licenses for such activities. Further, Wildflower is advancing two applications to grow and distribute medical marijuana under an MMPR license with Health Canada.Wildflower’s proprietary growing system is designed to maximize crop yields and consistently produce pure clean pharmaceutical grade BC cannabis for patients and cannabinoid research. CSE:SUN – Last closing price .22
PUF Ventures Inc.
PUF Ventures Inc. has an experienced management team with a growth strategy to develop a diversified portfolio of projects that can be taken into production. The Company’s main objective is to add shareholder value through cost efficient acquisitions, joint ventures, and effective marketing while maintaining a lower risk profile through project diversification and sound financial management. PUF Ventures entered the burgeoning Canadian Medical Marijuana market by making a passive investment in AAA Heidelberg for a non-controlling 16.5% equity interest and signing a Letter of Intent whereby the Company has been granted the exclusive option to acquire the balance of the interest in AAA Heidelberg for a 100% ownership.About AAA Heidelberg, Since December 2013 AAA Heidelberg has had an application pending with Health Canada for a new MMPR (Marihuana for Medical Purposes Regulations) license for the production of up to 1,320 pounds of marijuana in the first year. AAA Heidelberg’s growing philosophy is based on using all-natural nutrients where young plants will be nurtured and carefully monitored to ensure healthy, pest-free vegetation. Over years they have developed superior growing methods and optimum conditions for highest quality yields time and again. Natural marihuana is highly effective in the treatment of numerous chronic ailments without harmful side effects. Selected varieties have been cultivated and refined for specific medicinal profiles.
All growing will take place in a climate controlled environment and under the supervision of experienced medical marihuana growers who were previously licensed under the Marihuana Medical Access Regulations (MMAR).
AAA Heidelberg’ first facility is a secure 8,800 square foot commercial building and land located in London, Ontario, which is undergoing extensive renovations to meet strict pharmaceutical quality standards.
The entire facility has been planned to meet the highest level of pharmaceutical standards and quality. It will feature automated systems for temperature, light, humidity, carbon dioxide, and special ventilation for bacteria control. The entire facility has been planned and is being built-out to meet the highest level of pharmaceutical standards. The last major remaining interrelated components of the build-out – the HVAC and Surna Water Chilled Climate Control equipment – are currently being installed. The final components consisting of grow lights, computer systems, and security hardware will follow shortly after. CSE:PUF – Last closing price .25
Cameo Resources Corp.
Cameo Resources Inc. is pleased to announce that the company has signed a Letter of Intent with Green Fields Hydroponics of Portland Oregon. This is step two in the process to develop and commercialize an initial hydroponics business. This first venture will use the GFH business model for a comprehensive plan to cultivate, process and sell marijuana and hemp products with an emphasis on medical uses. TSX:CRU Last closing price .06
|
TECHNOLOGY
InMed Pharmaceuticals is a clinical stage biopharmaceutical company that specializes in developing therapies through the Research and Development into the extensive pharmacology of cannabinoids coupled with innovative drug delivery systems.
InMed is utilizing its proprietary "Intelligent Cannabinoid Drug Design Platform" to identify new bioactive compounds within the cannabis plant that interact with certain gene responsible for specific diseases.
Our Proprietary Platform Technology, Product pipeline and accelerated drug discovery/development pathway are the fundamental value drivers of the Company. CSE:IN - Last closing price .19
Through its Washington State subsidiary, New Age Farm owns two properties, one located in Sumas, WA, and the other in Oroville, WA where it intends to offer fully built out turnkey service operations to licensed I-502 tenant-growers who will lease the facilities for production and processing. With three leases already in place, operations in Washington State have begun in Oroville and will expand further as the Company completes its build out. CSE:NF – Last closing price .09
The issuer is a licensed producer and engaged in the business of developing technologies, products and services to support the Cannabis industry. CSE:THC – Last closing price .98
Cannabix Technologies Inc. is a leader in marijuana breathalyzer developmentfor law enforcement and the workplace. Cannabix is actively developing breath testing technologies in the pursuit of bringing durable, portable hand-held tools to market to enhance detection of marijuana impaired driving offences on roads at a time when marijuana is becoming legal in many jurisdictions globally. Currently in a joint venture with the University of Florida.CSE:BLO – Last closing price .60
Affinor is focused on the design, development and commercialization of vertical farming technology for both indoor and outdoor (greenhouse) applications. Affinor’s patent technology and licensed patent pending technology positions the Company well in the vertical farming industry. It is the only vertically integrated technology that can offer patented inline automated pollination for fruiting crops. Affinor can offer software driven growing solutions automating high quality, scientifically engineered products and process.
Affinor has an agreement with THC BioMed located in Kelowna, BC to trial cannabis with our technology. As cannabis becomes more established in North America, cost effective commercial production and greenhouse systems will be used as the market stabilizes and competitive advantage is achieved via efficiencies. Affinor sees this as an opportunity to diversity our technology into other markets with high value crops and be the first vertical system actively growing cannabis in Canada. Affinor will be fabricating and shipping a working prototype to THC BioMed in the fall 2016.
As well, Affinor has an option agreement to acquire a cannabis production license from D&G Inc if they are successful in obtaining a legal federal license. Once owned by Affinor, D&G Inc. is currently still in the review process of their application for the MMPR, which is now the ACMPR. Under the agreement, Affinor has the option to acquire the license once issued. If exercised, this would be an opportunity for Affinor to have a legal cannabis RD and cultivation center. This was the original intention acquiring D&G Inc, however, obtaining a license from Health Canada took longer than expected and Affinor decided to partner with THC BioMed to help conduct growth trials in the cannabis market directly. CSE:AFI Last closing price .155
Arcturus Growthstar Technologies Inc.
Arcturus Growthstar Technologies Inc. (AGT) is rapidly becoming a leading indoor plant growth technology company specializing in LED lighting and vertical farming solutions.
AGT’s business model includes developing and acquiring technologies that will further its position as a leader in the evolving Controlled Environment Agriculture (CEA) market for the global production of various types of plants. The Company holds a worldwide license to use a patented vertical farming technology that, when compared to traditional plant production methods, generate yields up to 10 times greater per square foot of land. The contained system provides many other benefits including seed to sale security, scalability, consistency due to year-round production, cost control, product safety and purity by eliminating environmental variability. CSE:AGS Last closing price .26
CALYX BIO-VENTURE
Calyx Bio-Ventures Inc., is an agri-tech company. In addition to owning a portfolio of proprietary intellectual property with applications in crop enhancement, Calyx’s wholly-owned subsidiary, Cannigistics Agri-Solutions Corp, has created a software platform tailored to the advanced indoor agriculture sector. The Cannigistics technology platform is designed to enhance the efficiency and effectiveness of any businesses operation, not only indoor agricultural, and with the backing of Calyx, Cannigistics is quickly positioning to become a leader in integrated technology solutions. CSE:CYX Last closing price .12
|
NUTRICEUTICALS & EDIBLES
Lifestyle Delivery Systems Inc.’s filmstrip technologies produce an oral delivery system that can be used for energy elixirs, herbal remedies and a smokeless alternative option to medical and recreational users of cannabis. The Company’s technology produces infused strips (similar to breath strips) that are not only a safer, healthier option to smoking but also a new way to accurately meter the dosage and assure the purity of the product. The Company will license the technology to licensees, who will in turn manufacture the strips where the legal use of marijuana is allowed. CSE:LDS – Last closing price .93
The Tinley Beverage Company
The Tinley Beverage Company is a functional beverage company focused on hemp-infused beverages and supplements. The company has the only patent-produced liquid supplement containing certifiable phytoconstituent-rich hemp oil. The company is producing its products in Los Angeles and is focusing distribution on key markets throughout the West Coast. Currently distribution exceeds fifty retail outlets in the state of California CSE:TNY – Last closing price .40
Nutritional High is primarily focused on developing, acquiring and designing products and brands in the marijuana-infused edible products and oil extracts sectors for medical and adult recreational use. The Company works exclusively in U.S. stateswhere such activity is permitted and regulated by state law, through entities which hold a valid license to produce marijuana-infused edible products and to distribute and dispense marijuana products. CSE:EAT – Last closing price .21
Lexaria is a food sciences company focused on the beneficial properties of cannabinoids and other molecules. In 2015 Lexaria introduced eleven new consumer food products all utilizing the benefits of its patent pending hemp oil infusion technology: Coffee, Hot Chocolate, 7 flavours of Tea, and 2 flavours of Protein Energy Bars. Lexaria has filed for patent protection in the US and Internationally for a unique delivery method of cannabinoids, vitamins, nicotine and non-steriodal anti-inflammatories (NSAIDs).
October 27, 2016) - Lexaria Bioscience Corp (CSE: LXX) (OTCQB: LXRP) has received its first patent from the U.S. Patent and Trademark Office titled, Cannabinoid Infused Food and Beverage Compositions and Methods of Use Thereof. This patent, which is valid for 20 years, pertains to Lexaria's method of improving bioavailability and taste of certain cannabinoid lipophilic active agents in food products.InvestmentPitch.com has produced a "video news alert" which discusses this news. If this link is not enabled, please visit www.InvestmentPitch.com and enter "Lexaria" in the search box. CSE:LXX – Last closing price .35
Finore Mining Inc. is a Canadian-based, advanced-stage exploration company with a focus on identifying and evaluating opportunities for the acquisition and, if warranted, development of a mineral resource property of merit. Expect a name change of this issuer in the near future.
October 27, 2016 (the “Assignment Agreement”) with an arm’s length private British Columbia company (the “Assignor”), pursuant to which the Assignor has assigned to the Company the rights and obligations of a letter agreement dated October 25, 2016 (the “Letter Agreement”) between the Assignor and Kushtown USA, LLC (“Kushtown”) a leading California marijuana beverage company. Pursuant to the terms of the Letter Agreement, the Company will acquire all of the issued and outstanding securities of Kushtown(the “Transaction”). CSE:FIN – Last closing price .34
Golden Leaf Holdings Ltd. is one of the largest cannabis oil and solution providers in North America. It's a leading cannabis products company in Oregon built around recognized brands. GLH leverages a strong management team with cannabis and food industry experience to complement its expertise in extracting, refining and selling cannabis oil. Click here for October 2016 Investor presentationCSE: GLH-Last closing price .69
October 26, 2016 – Tetra Bio-Pharma Inc. (“Tetra Bio” or the “Company”), through its subsidiary, Agro-Tek Inc. (“AGTK”), is pleased to announce that it has acquired multiple intellectual property assets related to the initiation of manufacturing and distribution of products for natural health care including products containing extracts or oils derived from Cannabis sativa. The assets acquired include proprietary formulations that have obtained marketing approval from Health Canada. The line consists of: 1. Glucose Aid; NPN 80058089 2. Kava Kava; NPN 80061986 3. Stress Ado; NPN 80065911 4. Toux Ado (Cough Ado); NPN 80065923 5. Toux enfant (Cough Children); NPN 80065928 6. Water Relax; NPN 80065948 (beverage supplement) 7. Water Cough; NPN 80066086(beverage supplement) 8. Sleep Pro; NPN 800666799. Instant Relief; NPN 80066682 (topical gel for local pain relief). CSE:TBP Last closing price .19
|
DIVERSIFIED/INDUSTRIALS
Alliance Growers Corp is a diversified cannabis company driven by the Company’s ‘Four Pillars’ Organization Plan- MMPR cannabis production facilities, distribution network, consumer products and research and development. The company was incorporated in 2014. Alliance Growers' head office is in Vancouver, BC and its interest in a marijuana production facility is in Kelowna, BC. ACG: CSE Last closing .18
Beleave Inc.
Beleave Inc. ("Beleave" or the "Company") is a biotech company focused on the production of medical marijuana in Canada. The Company's wholly-owned subsidiary First Access Medical Inc. has applied for a license to cultivate and sell medical marijuana at its facility pursuant to the Access to Cannabis for Medical Purposes Regulations outlined by Health Canada. The Company is actively working towards the development of patents through research with large Canadian institutions and the research and development of smoke harm reduction products. CSE:BE Last closing price .19
True Leaf Medicine International Ltd., through its wholly-owned subsidiary ‘True Leaf Pet’, is entering the $60 billion pet industry with a line of hemp-focused pet chews and supplements marketed through natural pet health and veterinary channels in Canada and the United States. The company has also filed an application under Health Canada’s Marihuana for Medicinal Purposes Regulations (MMPR) to become a Canadian licensed producer through its ‘True Leaf Medicine’ subsidiary. It has passed through the preliminary and enhanced screening process of Health Canada’s review and is currently awaiting security clearance and ‘pre-licensing inspection’ approval. CSE:MJ – Last closing price .24
Veritas Pharma Inc.
Veritas Pharma Inc. (trading symbol CSE:VRT) is an early stage pharmaceutical company developing innovative medicinal cannabis cultivars for specific disease conditions such as chronic pain, emesis (nausea/vomiting), and epilepsy. Using a ‘lean and mean’ approach to product development, the company aims to select candidate cultivars using classical pharmacology techniques and then immediately evaluate them in the clinic to maximize both product value and shareholder return. Veritas’s scientists are an inter-disciplinary team that consists of chemists, pharmacologists, anesthetists, and clinical pharmacologists. Their focus is to use their knowledge to streamline the development of cannabis based treatments to capture considerable market share. Also through its wholly owned subsidiary, Sechelt Organic Marijuana Corp., has applied to Health Canada for a medical marijuana production and distribution license under the Marihuana for Medical Purposes Regulations (the “MMPR“). CSE:VRT Last closing price .29
Laguna Blends Inc. “Laguna” is a network marketing company focused on the nutritional health benefits that are derived from hemp.Laguna has independent affiliates that generate retail sales and have the ability to recruit other affiliates. In addition, Laguna is the first network marketing company to use virtual 3D technology to enable affiliates to train, recruit and promote sales by utilizing a simple interactive platform.
October 24, 2016 – Laguna Blends Inc. announces its European sales, marketing and distribution strategy to penetrate the European market. Laguna intends to enter the multibillion dollar bottled water and skin care market in Europe by joint venture and/or licensing opportunities.
Laguna is working with a German based consulting group (“Consultants”) that are connected to some of Europe’s largest retail chains and home shopping networks.
Laguna intends Germany to be the first market in which it will launch its Cannabidiol (CBD) products and then plans to subsequently expand into the rest of Europe. CBD’s are legal in Germany and this provides Laguna with an incredible market opportunity. Germany has a population of 80.6 million people.
Laguna has the exclusive distribution rights for Germany for both Carlsbad CBD Water and CannaCeuticals CBD Skin Care Products. CSE:LAG – Last closing price .42
Global Hemp Group Inc. is focused on acquiring and/or joint venturing with companies across all sectors of the hemp and cannabis industries in an effort to build a “soil-to-shelf” portfolio of complementary companies that will enable GHG to capture cash flow, revenues and value from its acquisitions and establish a far greater collective valuation than GHG or the individual companies would have on their own. Initial revenues will be generated from its environmental impact solutions and hemp consulting businesses. CSE:GHG Last closing price .04
iAnthus Capital Holdings, Inc., through its 100% owned subsidiary, iAnthus Capital Management, LLC, delivers a comprehensive solution for financing and managing licensed cannabis cultivators, processors and dispensaries throughout the United States. Founded by entrepreneurs with decades of experience in investment banking, corporate finance, law and healthcare services, iAnthus provides a unique combination of capital and hands-on operating and management expertise. The Company harnesses these skills to support a diversified portfolio of cannabis industry investments for its shareholders, including direct equity investments in for-profit license holders and lending facilities coupled with management services to not-for-profit license holders. CSE: IAN Last closing price $3.70
|